Recent Updates
Recently added Catalysts
KPTI Positive Sentiment Score: 70/100

Karyopharm to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023

Wednesday, February 8, 2023 1 min read
Key Takeaway: Karyopharm Therapeutics Inc. has announced that it will report its fourth quarter and full year 2022 financial results on February 15, 2023. The company will host a conference call at 8:00 a.m. ET on that date to discuss the financial outcomes and provide further updates about its operations. Investors can access the call via phone or a live audio webcast on the company's website. Karyopharm is recognized for its innovative cancer therapies, particularly XPOVIO® and NEXPOVIO®.

Market Sentiment Analysis

POSITIVE FACTORS

  • Karyopharm Therapeutics is reporting financial results indicating growth.
  • The upcoming conference call suggests transparency and investor engagement.
  • The successful launch of Karyopharm's novel cancer therapies is indicative of innovation in their pipeline.

Full Press Release Details

-- Conference Call Scheduled for Wednesday, February 15, 2023, at 8:00 a.m. ET --
NEWTON, Mass., Feb. 8, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report fourth quarter and full year 2022 financial results on Wednesday, February 15, 2023. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Wednesday, February 15, 2023, to discuss the financial results and other company updates.
To access the conference call, please dial (888) 349-0102 (local) or (412) 902-4299 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
SOURCE Karyopharm Therapeutics Inc.

21 %

more press release views with

Frequently Asked Questions

When will Karyopharm report its Q4 and full year 2022 results?

Karyopharm will report its financial results on February 15, 2023.

What time is the Karyopharm conference call scheduled?

The conference call is scheduled for 8:00 a.m. ET on February 15, 2023.

How can I access Karyopharm's conference call?

You can access it by dialing (888) 349-0102 for local or (412) 902-4299 for international.

Where can I find the archived webcast of the call?

The archived webcast will be available on Karyopharm's website two hours after the event.

What are the trademarks of Karyopharm Therapeutics?

XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.

Tags: KPTI Viatris Investor Conferences Healthcare Karyopharm Therapeutics financial results Q4 2022 cancer therapies
Last updated: Feb 8, 2023